Altered expression of fibroblast growth factor receptors in human pituitary adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1160-1166

  Abbass, S Ali Asghar ^a   Asa, Sylvia L ^a   Ezzat, Shereen ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RECEPTOR SUBTYPE; RNA;

ADENOHYPOPHYSIS; ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030904029     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.4.3896     Document Type: Article

References (56)

1. Alexander JM, Biller BMK, Bikkal H, Zervas NT, Arnold A, Klibanski A. 1990 Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest. 86:336-340.
2. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. 1990 Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 71:1427-1433.
3. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL. 1992 Ras mutations in human pituitary tumors. J Clin Endocrinol Metab. 74:914-919.
4. Herman V, Drazin NZ, Gonsky R, Melmed S. 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab. 77:50-55.
5. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D. 1994 H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab. 78:842-846.
6. Cai WY, Alexander JM, Hedley-Whyte ET, et al. 1994 ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab. 78:89-93.
7. Sumi T, Stefaneanu L, Kovacs K, Asa SL, Rindi G. 1993 Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol. 4:95-99.
8. Alvaro V, Lévy L, Dubray C, et al. 1993 Invasive human pituitary tumors express a point-mutated a-protein kinase-C. J Clin Endocrinol Metab. 77:1125-1129.
9. Cryns VL, Alexander JM, Klibanski A, Arnold A. 1993 The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab. 77:644-646.
10. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM. 1994 Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab. 78:922-927.
11. Woloschak M, Roberts JL, Post KD. 1994 Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer. 74:693-696.
12. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-568.
13. Harris PE, Alexander JM, Bikkal HA, et al. 1992 Glycoprotein hormone α-subunit production in somatotroph adenomas with and without Gsα mutations. J Clin Endocrinol Metab. 75:918-923.
14. s α-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab. 77:765-769.
15. Brystom C, Larsson C, Blomberg C, Sandelin K, Falkmer E. 1990 Localization of the MEN-1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA. 87:1968-1972.
16. Reichlin S. 1991 Pathogenesis of pituitary tumors. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary adenomas: new trends in basic and clinical research. Amsterdam: Elsevier; 113-121.
17. Ezzat S. 1992 Hypophysiotropic regulation of anterior pituitary hormones: cellular and molecular mechanisms. In: Selman WR, ed. Neuroendocrinology. Baltimore: Williams and Wilkins; 3-18.
18. Asa SL, Kovacs K, Stefaneanu L, et al. 1992 Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology. 131:2083-2089.
19. Asa SL, Kovacs K, Stefaneanu L, et al. 1990 Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone. Proc Soc Exp Biol Med. 193:232-235.
20. Ezzat S, Melmed S. 1990 The role of growth factors in the pituitary. J Endocrinol Invest. 13:691-698.
21. Webster J, Ham J, Bevan JS, Scanlon MF. 1989 Growth factors and pituitary tumors. Trends Endocrinol Metab. 1:95-98.
22. Mason IJ. 1994 The ins and outs of fibroblast growth factors. Cell. 78:547-552.
23. Becker D, Meier CD, Herlyn M. 1989 Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J. 8:3685-3691.
24. Baird A, Mormède P, Ying S-Y, et al. 1985 A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proc Natl Acad Sci USA. 82:5545-5549.
25. Larson GH, Koos RD, Sortino MA, Wise PM. 1990 Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay. Endocrinology. 126:927-932.
26. Ezzat S, Smyth HS, Ramyar L, Asa SL. 1995 Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab. 80:878-884.
27. Ezzat S, Horvath E, Kovacs K, Smyth HS, Singer W, Asa SL. 1995 Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocr Pathol. 6:125-134.
28. Ueba T, Nosaka T, Takahashi JA, et al. 1994 Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc Natl Acad Sci USA. 91:9009-9013.
29. Li Y, Koga M, Kasayama S, et al. 1992 Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. J Clin Endocrinol Metab. 75:1436-1441.
30. Prysor-Jones RA, Silverlight JJ, Jenkins JS. 1989 Oestradiol, vasoactive intestinal peptide and fibroblast growth factor in the growth of human pituitary tumour cells in vitro. J Endocrinol. 120:171-177.
31. Atkin SL, Landolt AM, Jeffreys RV, Diver M, Radcliffe J, White MC. 1993 Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation. J Clin Endocrinol Metab. 77:831-837.
32. Inoue K, Sakai T, Hattori M. 1991 The cell-adhesive effect of basic fibroblast growth factor on pituitary cells in vitro. J Endocrinol. 130:381-386.
33. Schweigerer L, Neufeld G, Gospodarowicz D. 1987 Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J Clin Invest. 80:1516-1520.
34. Givol D, Yayon A. 1992 Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6:3362-3369.
35. Roghani MJ, Mansukhani A, Dell'Era P, et al. 1994 Heparin increases the affinity of fibroblast growth factor for its receptor but is not required for binding. J Biol Chem. 269:3976-3984.
36. Yan G, Wang F, Fukabori Y, Sussman D, Hou J, McKeehan WL. 1992 Expression and transformation of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the exon at alternate 3′-acceptor site. Biochem Biophys Res Commun. 183:423-430.
37. Peters KG, Werner S, Chen G, Williams LT. 1992 Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development. 114:233-243.
38. Morrison RS, Yamaguchi F, Saya H, et al. 1994 Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol. 18:207-216.
39. Morrison RS, Gross JL, Herblin WF, et al. 1990 Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res. 50:2524-2529.
40. Luqmani YA, Graham M, Coombes RC. 1992 Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer. 66:273-280.
41. Di Blasio AM, Cremonesi L, Viganó P, et al. 1993 Basic fibroblast growth factor and its receptor messenger ribonucleic acids are expressed in human ovarian epithelial neoplasms. Am J Obstet Gynecol. 169:1517-1523.
42. Crickard K, Gross JL, Crickard U, et al. 1994 Basic fibroblast growth factor and receptor expression in human ovarian cancer. Gynecol Oncol. 55:277-284.
43. Ezzat S, Walpola IA, Ramyar L, Smyth HS, Asa SL. 1995 Membrane-anchored expression of transforming growth factor-α in human pituitary adenoma cells. J Clin Endocrinol Metab. 80:534-539.
44. Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL. 1995 Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab. 80:3621-3627.
45. Penault-Llorca F, Bertucci F, Adélaïde J, et al. 1995 Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer. 61:170-176.
46. Asa SL, Bamberger A-M, Cao B, Wong M, Parker KL, Ezzat S. 1996 The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab. 81:2165-2170.
47. Puy LA, Asa SL. 1996 The ontogeny of pit-1 expression in the human fetal pituitary gland. Neuroendocrinology. 63:349-355.
48. Penabad JL, Bashey HM, Asa SL, et al. 1996 Decreased follistatin gene expression in gonadotroph adenomas. J Clin Endocrinol Metab. 81:3397-3403.
49. Hsu S-M, Soban E. 1982 Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem. 30:1079-1082.
50. Ron D, Reich R, Chedid M, et al. 1993 Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J Biol Chem. 268:5388-5394.
51. Vainikka S, Partanen J, Bellosta F, et al. 1992 Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J. 11:4273-4280.
52. Crumley G, Bellot F, Kaplow JM, Schlessinger J, Jaye M, Dionne CA. 1991 High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF. Oncogene. 6:2255-2262.
53. Vainikka S, Joukov V, Wennstrom S, Bergman M, Pelicci PG, Alitalo K. 1994 Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J Biol Chem. 269:18320-18326.
54. Mohammadi M, Dionne CA, Li W, et al. 1992 Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 358:681-683.
55. Vainikka S, Joukov V, Klint P, Alitalo K. 1996 Association of a 85-kDa serine kinase with activated fibroblast growth factor receptor-4. J Biol Chem. 271:1270-1273.
56. Johnston CL, Cox HC, Gomm JJ, Coombes RC. 1995 bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement. Biochem J. 306:609-616.